ICD-11 code : 4A40.1;
Preferred Label : Drug-induced lupus erythematosus;
ICD-11 definition : Drug-induced lupus erythematosus is a syndrome in which positive antinuclear antibodies
are associated with symptoms, such as fever, malaise, arthritis, intense arthralgia/myalgia,
serositis, and/or rash. The syndrome appears during therapy with certain medications
(e.g., procainamide, hydralazine, phenytoin) and tumor necrosis factor inhibitors.
It occurs predominantly in Caucasians, has less female predilection than SLE, rarely
involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated
with antibodies to histones, and usually resolves over several weeks after discontinuation
of the offending medication.;
ICD-11 synonym : drug-induced systemic lupus erythematosus;
Origin ID : 1239818910;
UMLS CUI : C0263591;
Currated CISMeF NLP mapping
- ICD-10 Mapping
- Semantic type(s)
- UMLS correspondences (same concept)
Drug-induced lupus erythematosus is a syndrome in which positive antinuclear antibodies
are associated with symptoms, such as fever, malaise, arthritis, intense arthralgia/myalgia,
serositis, and/or rash. The syndrome appears during therapy with certain medications
(e.g., procainamide, hydralazine, phenytoin) and tumor necrosis factor inhibitors.
It occurs predominantly in Caucasians, has less female predilection than SLE, rarely
involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated
with antibodies to histones, and usually resolves over several weeks after discontinuation
of the offending medication.
